635 A study of SRL 172 (mycobacterium vaccae) as the first component of a tumour vaccine with immunological changes and clinical activity in patients with lung cancer
- DOI
- 10.1016/s0169-5002(97)80015-3
- Published
- 1997-08
- Container
- Lung Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s0169-5002-97-80015-3,
title = {635 A study of SRL 172 (mycobacterium vaccae) as the first component of a tumour vaccine with immunological changes and clinical activity in patients with lung cancer},
author = {M.E.R. O'Brien and K. Bromelow and J. Prendiville and C. Rees and M. Hill and J. Stanford and J. Grange and F. Farzaneh and I.E. Smith and B.E. Souberbielle},
year = {1997},
journal = {Lung Cancer},
doi = {10.1016/s0169-5002(97)80015-3},
url = {https://doi.org/10.1016/s0169-5002(97)80015-3}
}RIS
TY - JOUR TI - 635 A study of SRL 172 (mycobacterium vaccae) as the first component of a tumour vaccine with immunological changes and clinical activity in patients with lung cancer AU - M.E.R. O'Brien AU - K. Bromelow AU - J. Prendiville AU - C. Rees AU - M. Hill AU - J. Stanford AU - J. Grange AU - F. Farzaneh AU - I.E. Smith AU - B.E. Souberbielle PY - 1997 JO - Lung Cancer DO - 10.1016/s0169-5002(97)80015-3 UR - https://doi.org/10.1016/s0169-5002(97)80015-3 ER -
APA
O'Brien, M., Bromelow, K., Prendiville, J., Rees, C., Hill, M., Stanford, J., Grange, J., Farzaneh, F., Smith, I., & Souberbielle, B. (1997). 635 A study of SRL 172 (mycobacterium vaccae) as the first component of a tumour vaccine with immunological changes and clinical activity in patients with lung cancer. Lung Cancer. https://doi.org/10.1016/s0169-5002(97)80015-3
Source records
- crossref · retrieved 2026-11-11T01:14:58.496Z